UPC_APP_3214/2025

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Procedural & sub-applicationsOther ProceduralMunich CDGenericWritten Phase

Overview Decisions Documents Timeline

Parties

Claimants

Name not displayed for GDPR reasons. Represented by Sture RYGAARD

Respondents

Sanofi-Aventis Deutschland GmbH(Sanofi Group)(Amgen Group)
Amgen Inc.(Sanofi Group)(Amgen Group)
Dehns(Sanofi Group)(Amgen Group)
Name not displayed for GDPR reasons. Represented by Oswin RIDDERBUSCH(Sanofi Group)(Amgen Group)

Judges

Ulrike Voß
Andras Kupecz
Casper Struve

Patents

EP3666797

CPC codes: C07K2317/14, C07K2317/34, A61K39/395, A61K2039/505, A61K31/366, A61P3/06, A61K31/66, A61K31/22, A61P9/00, A61P7/00, A61P25/28, A61K2300/00…

Sector: Biotechnology

Outcome

—

Filed: Jan 21, 2025

First decided: —

Language: English

Open on UPC Registry